CAUSE WE'RE NOT GETTING ANY YOUNGER Trademark

Trademark Overview


On Thursday, September 12, 2024, a trademark application was filed for CAUSE WE'RE NOT GETTING ANY YOUNGER with the United States Patent and Trademark Office. The USPTO has given the CAUSE WE'RE NOT GETTING ANY YOUNGER trademark a serial number of 98747318. The federal status of this trademark filing is APPROVED FOR PUBLICATION as of Monday, June 1, 2026. This trademark is owned by Senotherapeutix, Inc.. The CAUSE WE'RE NOT GETTING ANY YOUNGER trademark is filed in the Pharmaceutical Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:

Anti-aging therapy in the nature of treatment of age-related conditions; Anti-aging services, namely treatment of age-related conditions; Anti-aging therapy in the nature of treatment to improve longevity; Medical services; Medical services, namely, anti-aging services in the nature of treatment of age-related condition; Medical services, namely, treatment of age-related disorders; Medical services in the nature of treatment to improve longevity; Healthcare consulting services in the fields of longevity and age-related conditions; Medical and pharmaceutical consultation services in the fields of improving longevity and treating age-related conditions; Medical advisory services; Medical advisory services in the field of anti-aging; Medical advisory services in the field of prevention and treatment of age-related disorders; Medical testing services; Medical testing services in the field of anti-aging; Medical testing services in the field of prevention and treatment of age-related disor...

Development of pharmaceutical preparations and medicines; Research and development of pharmaceuticals for the treatment of age-related diseases and cancer; Testing, inspection, research, or development of pharmaceutical preparations for age therapy and gene therapy; Consulting services in the fields of biotechnology, pharmaceutical research and development, and pharmacogenetics for age therapy and gene therapy; Biological research and analysis namely, biologic age scoring; Biological research and analysis, namely, statistical scoring to determine a biologic age score of a patient; Medical research Laboratory services; Medical research Laboratory services related to biologic age; Medical research Laboratory services related to biological age scoring; Medical research Laboratory services related to determining a number or percentage of senescent cells; Medical research services; Medical research services, in the field of anti-aging; Medical research services in the nature of treatment o...

Pharmaceutical products for the prevention and treatment of cancer and other age-related skin disorders; Gene therapy-based pharmaceutical products for the prevention and treatment of cancer and other age-related skin disorders

General Information


Serial Number98747318
Word MarkCAUSE WE'RE NOT GETTING ANY YOUNGER
Filing DateThursday, September 12, 2024
Status680 - APPROVED FOR PUBLICATION
Status DateMonday, June 1, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Pseudo MarkBECAUSE WE ARE NOT GETTING ANY YOUNGER
Goods and ServicesAnti-aging therapy in the nature of treatment of age-related conditions; Anti-aging services, namely treatment of age-related conditions; Anti-aging therapy in the nature of treatment to improve longevity; Medical services; Medical services, namely, anti-aging services in the nature of treatment of age-related condition; Medical services, namely, treatment of age-related disorders; Medical services in the nature of treatment to improve longevity; Healthcare consulting services in the fields of longevity and age-related conditions; Medical and pharmaceutical consultation services in the fields of improving longevity and treating age-related conditions; Medical advisory services; Medical advisory services in the field of anti-aging; Medical advisory services in the field of prevention and treatment of age-related disorders; Medical testing services; Medical testing services in the field of anti-aging; Medical testing services in the field of prevention and treatment of age-related disorders; Medical services in the field of anti-aging; Medical services in the field of senescent cells; Medical services in the field of age-related disorders; Medical testing services in the nature of performing biopsies in the field of senescent cells; Medical testing services in the nature of performing biopsies in the field of disorders related to biologic age; Medical testing services in the nature of performing biopsies in the field of biological age scoring; Medical testing services in the nature of performing biopsies in the field of related to determining a number or percentage of senescent cells; Non-invasive medical testing services; Non-invasive medical testing services related to biologic age; Non-invasive medical testing services related to biological age scoring; Non-invasive medical testing services related to determining a number or percentage of senescent cells
Goods and ServicesDevelopment of pharmaceutical preparations and medicines; Research and development of pharmaceuticals for the treatment of age-related diseases and cancer; Testing, inspection, research, or development of pharmaceutical preparations for age therapy and gene therapy; Consulting services in the fields of biotechnology, pharmaceutical research and development, and pharmacogenetics for age therapy and gene therapy; Biological research and analysis namely, biologic age scoring; Biological research and analysis, namely, statistical scoring to determine a biologic age score of a patient; Medical research Laboratory services; Medical research Laboratory services related to biologic age; Medical research Laboratory services related to biological age scoring; Medical research Laboratory services related to determining a number or percentage of senescent cells; Medical research services; Medical research services, in the field of anti-aging; Medical research services in the nature of treatment of age-related disorders
Goods and ServicesPharmaceutical products for the prevention and treatment of cancer and other age-related skin disorders; Gene therapy-based pharmaceutical products for the prevention and treatment of cancer and other age-related skin disorders

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, September 12, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, September 12, 2024
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, September 12, 2024
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameSenotherapeutix, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSurfside, FL 33154
US

Trademark Events


Event DateEvent Description
Thursday, September 12, 2024NEW APPLICATION ENTERED
Thursday, March 20, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, March 21, 2025ASSIGNED TO EXAMINER
Monday, March 31, 2025NON-FINAL ACTION WRITTEN
Monday, March 31, 2025NON-FINAL ACTION E-MAILED
Monday, March 31, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, June 25, 2025ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Monday, June 30, 2025APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Monday, June 30, 2025APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Monday, September 29, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, September 29, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, October 8, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, November 4, 2025FINAL REFUSAL WRITTEN
Tuesday, November 4, 2025FINAL REFUSAL E-MAILED
Tuesday, November 4, 2025NOTIFICATION OF FINAL REFUSAL EMAILED
Wednesday, February 4, 2026APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Wednesday, February 4, 2026APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Monday, May 4, 2026TEAS REQUEST FOR RECONSIDERATION RECEIVED
Monday, May 4, 2026CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, May 4, 2026TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, May 5, 2026EXAMINERS AMENDMENT -WRITTEN
Tuesday, May 5, 2026EXAMINERS AMENDMENT E-MAILED
Tuesday, May 5, 2026NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, May 5, 2026EXAMINER'S AMENDMENT ENTERED
Monday, June 1, 2026APPROVED FOR PUB - PRINCIPAL REGISTER